Financials data is unavailable for this security.
View more
Year on year Somnomed Ltd grew revenues 21.63% from 91.68m to 111.52m while net income improved from a loss of 12.24m to a smaller loss of 3.46m.
| Gross margin | 59.86% |
|---|---|
| Net profit margin | -3.10% |
| Operating margin | -0.68% |
| Return on assets | -4.58% |
|---|---|
| Return on equity | -7.56% |
| Return on investment | -6.76% |
More ▼
Cash flow in AUDView more
In 2025, Somnomed Ltd increased its cash reserves by 6.89%, or 1.11m. The company earned 7.78m from its operations for a Cash Flow Margin of 6.98%. In addition the company used 3.98m on investing activities and also paid 3.38m in financing cash flows.
| Cash flow per share | 0.0108 |
|---|---|
| Price/Cash flow per share | 67.25 |
| Book value per share | 0.2147 |
|---|---|
| Tangible book value per share | 0.1152 |
More ▼
Balance sheet in AUDView more
| Current ratio | 1.51 |
|---|---|
| Quick ratio | 1.25 |
| Total debt/total equity | 0.173 |
|---|---|
| Total debt/total capital | 0.1475 |
More ▼
